[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fkCml4d0QWA2pdf5r5oqSuU3E-IuT0mBpTfoBwTcFN1c":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":35,"phaseBuckets":76,"rows":83},"State University of New York at Buffalo",[4],280,false,72,14,41901,220,[13,16,19,22,25,27,30,32],{"name":14,"count":15},"Multiple Sclerosis",10,{"name":17,"count":18},"Hyperthermia",9,{"name":20,"count":21},"Obesity",8,{"name":23,"count":24},"Diabetes Mellitus, Type 2",7,{"name":26,"count":24},"Pediatric Obesity",{"name":28,"count":29},"Type 2 Diabetes",5,{"name":31,"count":29},"Fatigue",{"name":33,"count":34},"Healthy",4,[36,41,46,51,56,61,66,71],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT03899402","Triple Therapy in T1DM","2026-01-31","Insulin",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT05418244","Inhaled Isopropyl Alcohol for Treatment of Nausea","2026-06-30","Oral Ondansetron",{"nctId":47,"briefTitle":48,"date":49,"intervention":50},"NCT06222593","Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC","2026-07-01","Bicalutamide in combination with Sunitinib",{"nctId":52,"briefTitle":53,"date":54,"intervention":55},"NCT06822049","Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)","2026-07-31","Combination Nicotine Replacement Therapy",{"nctId":57,"briefTitle":58,"date":59,"intervention":60},"NCT07393503","Musculoskeletal Outcomes Using Tylenol\u002FIbuprofen vs. Oral Steroids in New Injuries","2026-08","Methylprednisolone 4Mg Tab",{"nctId":62,"briefTitle":63,"date":64,"intervention":65},"NCT07120763","Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures","2026-08-22","Ketamine + Lidocaine",{"nctId":67,"briefTitle":68,"date":69,"intervention":70},"NCT06463743","Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)","2027-01-01","metformin",{"nctId":72,"briefTitle":73,"date":74,"intervention":75},"NCT07587775","The Effect of Osteoporotic Medications on Vertebral Bone Quality Score","2028-06-01","Abaloparatide",[77,78,79,80,81,82],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[84,111,129,147,171,195,219,237,255,281,299,317,339,360,382,441,464,489,515,533,558,585,612,630,648,673,696,722,740,766,791,849,884,908,933,959,977,1003,1027,1045,1063,1081,1107,1125,1143,1161,1179,1197,1234,1269,1302,1320,1346,1371,1389,1413,1435,1460,1485,1512,1545,1570,1595,1620,1644,1662,1690,1708,1726,1744,1768,1790,1813,1839,1857,1875,1900],{"intervention":60,"totalTrials":85,"cells":86},1,{"EARLY_PHASE1":87,"PHASE1":90,"PHASE2":92,"PHASE3":94,"PHASE4":96,"NA":109},{"trials":88,"activeCount":89},[],0,{"trials":91,"activeCount":89},[],{"trials":93,"activeCount":89},[],{"trials":95,"activeCount":89},[],{"trials":97,"activeCount":85,"soonestReadout":59},[98],{"nctId":57,"briefTitle":58,"status":99,"phases":100,"primaryCompletion":59,"completion":101,"start":102,"enrollment":103,"conditions":104,"interventions":106},"ENROLLING_BY_INVITATION",[81],"2027-01","2025-09-17",60,[105],"Musculoskeletal Pain",[60,107,108],"Acetaminophen 500Mg Tab","Ibuprofen 200Mg Oral",{"trials":110,"activeCount":89},[],{"intervention":107,"totalTrials":85,"cells":112},{"EARLY_PHASE1":113,"PHASE1":115,"PHASE2":117,"PHASE3":119,"PHASE4":121,"NA":127},{"trials":114,"activeCount":89},[],{"trials":116,"activeCount":89},[],{"trials":118,"activeCount":89},[],{"trials":120,"activeCount":89},[],{"trials":122,"activeCount":85,"soonestReadout":59},[123],{"nctId":57,"briefTitle":58,"status":99,"phases":124,"primaryCompletion":59,"completion":101,"start":102,"enrollment":103,"conditions":125,"interventions":126},[81],[105],[60,107,108],{"trials":128,"activeCount":89},[],{"intervention":108,"totalTrials":85,"cells":130},{"EARLY_PHASE1":131,"PHASE1":133,"PHASE2":135,"PHASE3":137,"PHASE4":139,"NA":145},{"trials":132,"activeCount":89},[],{"trials":134,"activeCount":89},[],{"trials":136,"activeCount":89},[],{"trials":138,"activeCount":89},[],{"trials":140,"activeCount":85,"soonestReadout":59},[141],{"nctId":57,"briefTitle":58,"status":99,"phases":142,"primaryCompletion":59,"completion":101,"start":102,"enrollment":103,"conditions":143,"interventions":144},[81],[105],[60,107,108],{"trials":146,"activeCount":89},[],{"intervention":45,"totalTrials":85,"cells":148},{"EARLY_PHASE1":149,"PHASE1":151,"PHASE2":153,"PHASE3":155,"PHASE4":167,"NA":169},{"trials":150,"activeCount":89},[],{"trials":152,"activeCount":89},[],{"trials":154,"activeCount":89},[],{"trials":156,"activeCount":85,"soonestReadout":44},[157],{"nctId":42,"briefTitle":43,"status":158,"phases":159,"primaryCompletion":44,"completion":44,"start":160,"enrollment":161,"conditions":162,"interventions":166},"RECRUITING",[79,80],"2022-04-20",84,[163,164,165],"Vomiting","Nausea","Children, Only",[45],{"trials":168,"activeCount":89},[],{"trials":170,"activeCount":89},[],{"intervention":55,"totalTrials":85,"cells":172},{"EARLY_PHASE1":173,"PHASE1":175,"PHASE2":177,"PHASE3":179,"PHASE4":191,"NA":193},{"trials":174,"activeCount":89},[],{"trials":176,"activeCount":89},[],{"trials":178,"activeCount":89},[],{"trials":180,"activeCount":85,"soonestReadout":54},[181],{"nctId":52,"briefTitle":53,"status":158,"phases":182,"primaryCompletion":54,"completion":183,"start":184,"enrollment":185,"conditions":186,"interventions":190},[79,80],"2027-02-28","2025-03-10",200,[187,188,189],"Remote vs. In-Person","Remote Visits","In-person Visits",[55],{"trials":192,"activeCount":89},[],{"trials":194,"activeCount":89},[],{"intervention":40,"totalTrials":85,"cells":196},{"EARLY_PHASE1":197,"PHASE1":199,"PHASE2":201,"PHASE3":203,"PHASE4":215,"NA":217},{"trials":198,"activeCount":89},[],{"trials":200,"activeCount":89},[],{"trials":202,"activeCount":89},[],{"trials":204,"activeCount":85,"soonestReadout":39},[205],{"nctId":37,"briefTitle":38,"status":206,"phases":207,"primaryCompletion":39,"completion":44,"start":208,"enrollment":209,"conditions":210,"interventions":212},"ACTIVE_NOT_RECRUITING",[79,80],"2019-05-01",78,[211],"Type 1 Diabetes Mellitus",[40,213,214],"Semaglutide","Dapagliflozin",{"trials":216,"activeCount":89},[],{"trials":218,"activeCount":89},[],{"intervention":213,"totalTrials":85,"cells":220},{"EARLY_PHASE1":221,"PHASE1":223,"PHASE2":225,"PHASE3":227,"PHASE4":233,"NA":235},{"trials":222,"activeCount":89},[],{"trials":224,"activeCount":89},[],{"trials":226,"activeCount":89},[],{"trials":228,"activeCount":85,"soonestReadout":39},[229],{"nctId":37,"briefTitle":38,"status":206,"phases":230,"primaryCompletion":39,"completion":44,"start":208,"enrollment":209,"conditions":231,"interventions":232},[79,80],[211],[40,213,214],{"trials":234,"activeCount":89},[],{"trials":236,"activeCount":89},[],{"intervention":214,"totalTrials":85,"cells":238},{"EARLY_PHASE1":239,"PHASE1":241,"PHASE2":243,"PHASE3":245,"PHASE4":251,"NA":253},{"trials":240,"activeCount":89},[],{"trials":242,"activeCount":89},[],{"trials":244,"activeCount":89},[],{"trials":246,"activeCount":85,"soonestReadout":39},[247],{"nctId":37,"briefTitle":38,"status":206,"phases":248,"primaryCompletion":39,"completion":44,"start":208,"enrollment":209,"conditions":249,"interventions":250},[79,80],[211],[40,213,214],{"trials":252,"activeCount":89},[],{"trials":254,"activeCount":89},[],{"intervention":65,"totalTrials":85,"cells":256},{"EARLY_PHASE1":257,"PHASE1":259,"PHASE2":261,"PHASE3":263,"PHASE4":277,"NA":279},{"trials":258,"activeCount":89},[],{"trials":260,"activeCount":89},[],{"trials":262,"activeCount":89},[],{"trials":264,"activeCount":85,"soonestReadout":64},[265],{"nctId":62,"briefTitle":63,"status":158,"phases":266,"primaryCompletion":64,"completion":267,"start":268,"enrollment":269,"conditions":270,"interventions":274},[80],"2027-08-22","2025-08-22",50,[271,272,273],"Distal Radius Fracture Reduction","Pain Control","Pediatric Fractures",[65,275,276],"Ketamine group","Fentanyl",{"trials":278,"activeCount":89},[],{"trials":280,"activeCount":89},[],{"intervention":275,"totalTrials":85,"cells":282},{"EARLY_PHASE1":283,"PHASE1":285,"PHASE2":287,"PHASE3":289,"PHASE4":295,"NA":297},{"trials":284,"activeCount":89},[],{"trials":286,"activeCount":89},[],{"trials":288,"activeCount":89},[],{"trials":290,"activeCount":85,"soonestReadout":64},[291],{"nctId":62,"briefTitle":63,"status":158,"phases":292,"primaryCompletion":64,"completion":267,"start":268,"enrollment":269,"conditions":293,"interventions":294},[80],[271,272,273],[65,275,276],{"trials":296,"activeCount":89},[],{"trials":298,"activeCount":89},[],{"intervention":276,"totalTrials":85,"cells":300},{"EARLY_PHASE1":301,"PHASE1":303,"PHASE2":305,"PHASE3":307,"PHASE4":313,"NA":315},{"trials":302,"activeCount":89},[],{"trials":304,"activeCount":89},[],{"trials":306,"activeCount":89},[],{"trials":308,"activeCount":85,"soonestReadout":64},[309],{"nctId":62,"briefTitle":63,"status":158,"phases":310,"primaryCompletion":64,"completion":267,"start":268,"enrollment":269,"conditions":311,"interventions":312},[80],[271,272,273],[65,275,276],{"trials":314,"activeCount":89},[],{"trials":316,"activeCount":89},[],{"intervention":75,"totalTrials":85,"cells":318},{"EARLY_PHASE1":319,"PHASE1":321,"PHASE2":323,"PHASE3":333,"PHASE4":335,"NA":337},{"trials":320,"activeCount":89},[],{"trials":322,"activeCount":89},[],{"trials":324,"activeCount":85,"soonestReadout":74},[325],{"nctId":72,"briefTitle":73,"status":326,"phases":327,"primaryCompletion":74,"completion":328,"start":329,"enrollment":103,"conditions":330,"interventions":332},"NOT_YET_RECRUITING",[79],"2028-12-31","2026-06-01",[331],"Lumbar Degenerative Disease",[75],{"trials":334,"activeCount":89},[],{"trials":336,"activeCount":89},[],{"trials":338,"activeCount":89},[],{"intervention":70,"totalTrials":85,"cells":340},{"EARLY_PHASE1":341,"PHASE1":343,"PHASE2":345,"PHASE3":354,"PHASE4":356,"NA":358},{"trials":342,"activeCount":89},[],{"trials":344,"activeCount":89},[],{"trials":346,"activeCount":85,"soonestReadout":69},[347],{"nctId":67,"briefTitle":68,"status":158,"phases":348,"primaryCompletion":69,"completion":349,"start":350,"enrollment":351,"conditions":352,"interventions":353},[79],"2027-06-01","2025-09-24",30,[14],[70],{"trials":355,"activeCount":89},[],{"trials":357,"activeCount":89},[],{"trials":359,"activeCount":89},[],{"intervention":50,"totalTrials":85,"cells":361},{"EARLY_PHASE1":362,"PHASE1":364,"PHASE2":366,"PHASE3":376,"PHASE4":378,"NA":380},{"trials":363,"activeCount":89},[],{"trials":365,"activeCount":89},[],{"trials":367,"activeCount":85,"soonestReadout":49},[368],{"nctId":47,"briefTitle":48,"status":158,"phases":369,"primaryCompletion":49,"completion":370,"start":371,"enrollment":372,"conditions":373,"interventions":375},[78,79],"2027-07-01","2024-10-01",28,[374],"Carcinoma, Renal Cell",[50],{"trials":377,"activeCount":89},[],{"trials":379,"activeCount":89},[],{"trials":381,"activeCount":89},[],{"intervention":383,"totalTrials":34,"cells":384},"Buprenorphine\u002Fnaloxone",{"EARLY_PHASE1":385,"PHASE1":387,"PHASE2":389,"PHASE3":391,"PHASE4":393,"NA":439},{"trials":386,"activeCount":89},[],{"trials":388,"activeCount":89},[],{"trials":390,"activeCount":89},[],{"trials":392,"activeCount":89},[],{"trials":394,"activeCount":89},[395,408,419,429],{"nctId":396,"briefTitle":397,"status":398,"phases":399,"primaryCompletion":400,"completion":400,"start":401,"enrollment":402,"conditions":403,"interventions":406},"NCT00552578","Buprenorphine as a Treatment in Opiate Dependent Pain Patients","TERMINATED",[81],"2008-10","2007-10",12,[404,405],"Opiate Addiction","Refractory Pain",[407,407],"buprenorphine\u002Fnaloxone",{"nctId":409,"briefTitle":410,"status":411,"phases":412,"primaryCompletion":413,"completion":413,"start":414,"enrollment":415,"conditions":416,"interventions":417},"NCT00879996","Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients","COMPLETED",[81],"2011-10","2009-04",54,[404],[418,383],"Methadone",{"nctId":420,"briefTitle":421,"status":411,"phases":422,"primaryCompletion":423,"completion":423,"start":424,"enrollment":425,"conditions":426,"interventions":428},"NCT01559454","Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients",[81],"2014-05","2012-02",19,[427],"Low Back Pain",[418,383],{"nctId":430,"briefTitle":431,"status":432,"phases":433,"primaryCompletion":434,"completion":434,"start":435,"enrollment":89,"conditions":436,"interventions":437},"NCT01015066","Comparison of Buprenorphine\u002FNaloxone With Naltrexone in Opioid Dependent Adolescents","WITHDRAWN",[81],"2014-06","2009-11",[404],[383,438],"Naltrexone",{"trials":440,"activeCount":89},[],{"intervention":418,"totalTrials":442,"cells":443},2,{"EARLY_PHASE1":444,"PHASE1":446,"PHASE2":448,"PHASE3":450,"PHASE4":452,"NA":462},{"trials":445,"activeCount":89},[],{"trials":447,"activeCount":89},[],{"trials":449,"activeCount":89},[],{"trials":451,"activeCount":89},[],{"trials":453,"activeCount":89},[454,458],{"nctId":409,"briefTitle":410,"status":411,"phases":455,"primaryCompletion":413,"completion":413,"start":414,"enrollment":415,"conditions":456,"interventions":457},[81],[404],[418,383],{"nctId":420,"briefTitle":421,"status":411,"phases":459,"primaryCompletion":423,"completion":423,"start":424,"enrollment":425,"conditions":460,"interventions":461},[81],[427],[418,383],{"trials":463,"activeCount":89},[],{"intervention":465,"totalTrials":85,"cells":466},"Amoxicillin",{"EARLY_PHASE1":467,"PHASE1":469,"PHASE2":471,"PHASE3":473,"PHASE4":475,"NA":487},{"trials":468,"activeCount":89},[],{"trials":470,"activeCount":89},[],{"trials":472,"activeCount":89},[],{"trials":474,"activeCount":89},[],{"trials":476,"activeCount":89},[477],{"nctId":478,"briefTitle":479,"status":432,"phases":480,"primaryCompletion":481,"completion":482,"start":483,"enrollment":89,"conditions":484,"interventions":486},"NCT05165212","Primary Care Amoxicillin Challenge",[81],"2025-12-31","2026-01-01","2024-12-31",[485],"Amoxicillin Allergy",[465],{"trials":488,"activeCount":89},[],{"intervention":490,"totalTrials":85,"cells":491},"Normal saline",{"EARLY_PHASE1":492,"PHASE1":494,"PHASE2":496,"PHASE3":498,"PHASE4":500,"NA":513},{"trials":493,"activeCount":89},[],{"trials":495,"activeCount":89},[],{"trials":497,"activeCount":89},[],{"trials":499,"activeCount":89},[],{"trials":501,"activeCount":89},[502],{"nctId":503,"briefTitle":504,"status":398,"phases":505,"primaryCompletion":506,"completion":506,"start":507,"enrollment":508,"conditions":509,"interventions":511},"NCT03066440","Double Blinded Randomized Control Trial of Types of IVF in Children With DKA",[81],"2024-03-18","2018-09-01",53,[510],"Diabetic Ketoacidosis",[490,512],"Lactated Ringers",{"trials":514,"activeCount":89},[],{"intervention":512,"totalTrials":85,"cells":516},{"EARLY_PHASE1":517,"PHASE1":519,"PHASE2":521,"PHASE3":523,"PHASE4":525,"NA":531},{"trials":518,"activeCount":89},[],{"trials":520,"activeCount":89},[],{"trials":522,"activeCount":89},[],{"trials":524,"activeCount":89},[],{"trials":526,"activeCount":89},[527],{"nctId":503,"briefTitle":504,"status":398,"phases":528,"primaryCompletion":506,"completion":506,"start":507,"enrollment":508,"conditions":529,"interventions":530},[81],[510],[490,512],{"trials":532,"activeCount":89},[],{"intervention":534,"totalTrials":85,"cells":535},"Lidocaine Cream 4%",{"EARLY_PHASE1":536,"PHASE1":538,"PHASE2":540,"PHASE3":542,"PHASE4":544,"NA":556},{"trials":537,"activeCount":89},[],{"trials":539,"activeCount":89},[],{"trials":541,"activeCount":89},[],{"trials":543,"activeCount":89},[],{"trials":545,"activeCount":89},[546],{"nctId":547,"briefTitle":548,"status":411,"phases":549,"primaryCompletion":550,"completion":550,"start":551,"enrollment":552,"conditions":553,"interventions":555},"NCT00533468","\"Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age.\"",[81],"2008-03","2007-03",70,[554],"Pain",[534],{"trials":557,"activeCount":89},[],{"intervention":559,"totalTrials":85,"cells":560},"Mitoxantrone",{"EARLY_PHASE1":561,"PHASE1":563,"PHASE2":565,"PHASE3":567,"PHASE4":569,"NA":583},{"trials":562,"activeCount":89},[],{"trials":564,"activeCount":89},[],{"trials":566,"activeCount":89},[],{"trials":568,"activeCount":89},[],{"trials":570,"activeCount":89},[571],{"nctId":572,"briefTitle":573,"status":411,"phases":574,"completion":575,"start":576,"enrollment":29,"conditions":577,"interventions":582},"NCT00304291","A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)",[81],"2004-05","2001-08",[578,579,580,581],"Neuromyelitis Optica","Myelitis, Transverse","Demyelinating Autoimmune Diseases, CNS","Autoimmune Diseases of the Nervous System",[559],{"trials":584,"activeCount":89},[],{"intervention":586,"totalTrials":85,"cells":587},"Propofol",{"EARLY_PHASE1":588,"PHASE1":590,"PHASE2":592,"PHASE3":594,"PHASE4":596,"NA":610},{"trials":589,"activeCount":89},[],{"trials":591,"activeCount":89},[],{"trials":593,"activeCount":89},[],{"trials":595,"activeCount":89},[],{"trials":597,"activeCount":89},[598],{"nctId":599,"briefTitle":600,"status":398,"phases":601,"primaryCompletion":602,"completion":602,"start":603,"enrollment":604,"conditions":605,"interventions":607},"NCT02111447","Post Anesthesia Emergence and Behavioral Changes in Children Undergoing MRI",[81],"2014-12","2014-01",6,[606],"Delirium on Emergence",[586,586,608,609],"Sevoflurane","Isoflurane",{"trials":611,"activeCount":89},[],{"intervention":608,"totalTrials":85,"cells":613},{"EARLY_PHASE1":614,"PHASE1":616,"PHASE2":618,"PHASE3":620,"PHASE4":622,"NA":628},{"trials":615,"activeCount":89},[],{"trials":617,"activeCount":89},[],{"trials":619,"activeCount":89},[],{"trials":621,"activeCount":89},[],{"trials":623,"activeCount":89},[624],{"nctId":599,"briefTitle":600,"status":398,"phases":625,"primaryCompletion":602,"completion":602,"start":603,"enrollment":604,"conditions":626,"interventions":627},[81],[606],[586,586,608,609],{"trials":629,"activeCount":89},[],{"intervention":609,"totalTrials":85,"cells":631},{"EARLY_PHASE1":632,"PHASE1":634,"PHASE2":636,"PHASE3":638,"PHASE4":640,"NA":646},{"trials":633,"activeCount":89},[],{"trials":635,"activeCount":89},[],{"trials":637,"activeCount":89},[],{"trials":639,"activeCount":89},[],{"trials":641,"activeCount":89},[642],{"nctId":599,"briefTitle":600,"status":398,"phases":643,"primaryCompletion":602,"completion":602,"start":603,"enrollment":604,"conditions":644,"interventions":645},[81],[606],[586,586,608,609],{"trials":647,"activeCount":89},[],{"intervention":649,"totalTrials":85,"cells":650},"Atropine",{"EARLY_PHASE1":651,"PHASE1":653,"PHASE2":655,"PHASE3":657,"PHASE4":659,"NA":671},{"trials":652,"activeCount":89},[],{"trials":654,"activeCount":89},[],{"trials":656,"activeCount":89},[],{"trials":658,"activeCount":89},[],{"trials":660,"activeCount":89},[661],{"nctId":662,"briefTitle":663,"status":411,"phases":664,"primaryCompletion":665,"completion":665,"start":666,"enrollment":103,"conditions":667,"interventions":670},"NCT01819064","Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants",[81],"2013-07","2013-02",[668,669],"Bradycardia","Arrhythmias",[649],{"trials":672,"activeCount":89},[],{"intervention":674,"totalTrials":85,"cells":675},"Natalizumab",{"EARLY_PHASE1":676,"PHASE1":678,"PHASE2":680,"PHASE3":682,"PHASE4":684,"NA":694},{"trials":677,"activeCount":89},[],{"trials":679,"activeCount":89},[],{"trials":681,"activeCount":89},[],{"trials":683,"activeCount":89},[],{"trials":685,"activeCount":89},[686],{"nctId":687,"briefTitle":688,"status":411,"phases":689,"primaryCompletion":690,"completion":690,"start":691,"enrollment":351,"conditions":692,"interventions":693},"NCT03046251","Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis",[81],"2023-12","2015-08",[14],[674],{"trials":695,"activeCount":89},[],{"intervention":697,"totalTrials":85,"cells":698},"atomoxetine",{"EARLY_PHASE1":699,"PHASE1":701,"PHASE2":703,"PHASE3":705,"PHASE4":707,"NA":720},{"trials":700,"activeCount":89},[],{"trials":702,"activeCount":89},[],{"trials":704,"activeCount":89},[],{"trials":706,"activeCount":89},[],{"trials":708,"activeCount":89},[709],{"nctId":710,"briefTitle":711,"status":411,"phases":712,"primaryCompletion":713,"completion":714,"start":715,"enrollment":716,"conditions":717,"interventions":719},"NCT00918567","Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD",[81],"2008-05","2008-09","2007-01",56,[718],"Attention Deficit Hyperactivity Disorder",[697],{"trials":721,"activeCount":89},[],{"intervention":438,"totalTrials":85,"cells":723},{"EARLY_PHASE1":724,"PHASE1":726,"PHASE2":728,"PHASE3":730,"PHASE4":732,"NA":738},{"trials":725,"activeCount":89},[],{"trials":727,"activeCount":89},[],{"trials":729,"activeCount":89},[],{"trials":731,"activeCount":89},[],{"trials":733,"activeCount":89},[734],{"nctId":430,"briefTitle":431,"status":432,"phases":735,"primaryCompletion":434,"completion":434,"start":435,"enrollment":89,"conditions":736,"interventions":737},[81],[404],[383,438],{"trials":739,"activeCount":89},[],{"intervention":741,"totalTrials":85,"cells":742},"Mirabegron",{"EARLY_PHASE1":743,"PHASE1":745,"PHASE2":747,"PHASE3":749,"PHASE4":751,"NA":764},{"trials":744,"activeCount":89},[],{"trials":746,"activeCount":89},[],{"trials":748,"activeCount":89},[],{"trials":750,"activeCount":89},[],{"trials":752,"activeCount":89},[753],{"nctId":754,"briefTitle":755,"status":432,"phases":756,"primaryCompletion":757,"completion":757,"start":758,"enrollment":89,"conditions":759,"interventions":763},"NCT02981459","Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women",[81],"2018-06","2017-12-08",[760,761,762],"Urinary Frequency\u002FUrgency","Bladder Irritable","Bladder Pain Syndrome",[741],{"trials":765,"activeCount":89},[],{"intervention":767,"totalTrials":85,"cells":768},"Ramelteon",{"EARLY_PHASE1":769,"PHASE1":771,"PHASE2":773,"PHASE3":775,"PHASE4":777,"NA":789},{"trials":770,"activeCount":89},[],{"trials":772,"activeCount":89},[],{"trials":774,"activeCount":89},[],{"trials":776,"activeCount":89},[],{"trials":778,"activeCount":89},[779],{"nctId":780,"briefTitle":781,"status":432,"phases":782,"primaryCompletion":783,"completion":784,"start":785,"enrollment":89,"conditions":786,"interventions":788},"NCT03265951","Ramelteon for Complex Insomnia in Veterans With PTSD",[81],"2019-09-30","2020-06-30","2018-01-01",[787],"Insomnia",[767],{"trials":790,"activeCount":89},[],{"intervention":792,"totalTrials":34,"cells":793},"Gabapentin",{"EARLY_PHASE1":794,"PHASE1":796,"PHASE2":815,"PHASE3":828,"PHASE4":845,"NA":847},{"trials":795,"activeCount":89},[],{"trials":797,"activeCount":89},[798,806],{"nctId":799,"briefTitle":800,"status":411,"phases":801,"primaryCompletion":691,"completion":691,"start":802,"enrollment":34,"conditions":803,"interventions":805},"NCT02056899","Maintenance Gabapentin to Prolong Pregnancy.",[78],"2013-06",[804],"Preterm Labor, Premature Birth",[792],{"nctId":807,"briefTitle":808,"status":411,"phases":809,"primaryCompletion":810,"completion":802,"start":811,"enrollment":812,"conditions":813,"interventions":814},"NCT01421264","Gabapentin's Effects on Insomnia in Patients With Recent Concussion",[78],"2012-12","2011-08",21,[787],[792],{"trials":816,"activeCount":89},[817],{"nctId":818,"briefTitle":819,"status":411,"phases":820,"primaryCompletion":821,"completion":822,"start":434,"enrollment":823,"conditions":824,"interventions":826},"NCT02163434","Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum",[79],"2019-10","2019-11",31,[825],"Hyperemesis Gravidarum",[792,827],"Metoclopramide",{"trials":829,"activeCount":89},[830],{"nctId":831,"briefTitle":832,"status":411,"phases":833,"primaryCompletion":834,"completion":834,"start":835,"enrollment":836,"conditions":837,"interventions":839},"NCT04429022","Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy",[80],"2022-05-31","2020-11-24",68,[838],"Pain, Postoperative",[792,840,841,842,843,844],"Acetaminophen","Celecoxib","Ketorolac","Hydromorphone","Oxycodone",{"trials":846,"activeCount":89},[],{"trials":848,"activeCount":89},[],{"intervention":850,"totalTrials":442,"cells":851},"Valsartan",{"EARLY_PHASE1":852,"PHASE1":854,"PHASE2":856,"PHASE3":858,"PHASE4":880,"NA":882},{"trials":853,"activeCount":89},[],{"trials":855,"activeCount":89},[],{"trials":857,"activeCount":89},[],{"trials":859,"activeCount":89},[860,871],{"nctId":861,"briefTitle":862,"status":411,"phases":863,"primaryCompletion":864,"completion":602,"start":666,"enrollment":865,"conditions":866,"interventions":868},"NCT05170061","24 Hour Ambulatory Cardiac Oxygen Consumption",[80],"2014-09",26,[867],"Hypertension",[869,850,870],"Nebivolol","Nebivolol\u002Fvalsartan combination",{"nctId":872,"briefTitle":873,"status":411,"phases":874,"primaryCompletion":875,"completion":875,"start":876,"enrollment":351,"conditions":877,"interventions":878},"NCT00657241","Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril",[80],"2010-04","2008-04",[867],[879,850],"Carvedilol CR",{"trials":881,"activeCount":89},[],{"trials":883,"activeCount":89},[],{"intervention":885,"totalTrials":85,"cells":886},"dalfampridine",{"EARLY_PHASE1":887,"PHASE1":889,"PHASE2":891,"PHASE3":893,"PHASE4":904,"NA":906},{"trials":888,"activeCount":89},[],{"trials":890,"activeCount":89},[],{"trials":892,"activeCount":89},[],{"trials":894,"activeCount":89},[895],{"nctId":896,"briefTitle":897,"status":411,"phases":898,"primaryCompletion":899,"completion":899,"start":900,"enrollment":901,"conditions":902,"interventions":903},"NCT02006160","Effects of Dalfampridine on Cognition in Multiple Sclerosis",[79,80],"2016-02","2011-12",61,[14],[885],{"trials":905,"activeCount":89},[],{"trials":907,"activeCount":89},[],{"intervention":909,"totalTrials":85,"cells":910},"Vapocoolent",{"EARLY_PHASE1":911,"PHASE1":913,"PHASE2":915,"PHASE3":917,"PHASE4":929,"NA":931},{"trials":912,"activeCount":89},[],{"trials":914,"activeCount":89},[],{"trials":916,"activeCount":89},[],{"trials":918,"activeCount":89},[919],{"nctId":920,"briefTitle":921,"status":411,"phases":922,"primaryCompletion":923,"completion":923,"start":924,"enrollment":925,"conditions":926,"interventions":928},"NCT06182631","Clinical Trial Testing Buzzy Bee vs Vapocoolant During IV Placement",[80],"2021-01-15","2019-07-15",172,[927],"Intravenous Administration",[909],{"trials":930,"activeCount":89},[],{"trials":932,"activeCount":89},[],{"intervention":934,"totalTrials":85,"cells":935},"Mayzent",{"EARLY_PHASE1":936,"PHASE1":938,"PHASE2":940,"PHASE3":942,"PHASE4":955,"NA":957},{"trials":937,"activeCount":89},[],{"trials":939,"activeCount":89},[],{"trials":941,"activeCount":89},[],{"trials":943,"activeCount":89},[944],{"nctId":945,"briefTitle":946,"status":398,"phases":947,"primaryCompletion":948,"completion":949,"start":950,"enrollment":21,"conditions":951,"interventions":953},"NCT04925557","Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis",[79,80],"2023-06-01","2023-08-05","2021-11-13",[952],"Secondary-progressive Multiple Sclerosis",[934,954],"Ocrevus",{"trials":956,"activeCount":89},[],{"trials":958,"activeCount":89},[],{"intervention":954,"totalTrials":85,"cells":960},{"EARLY_PHASE1":961,"PHASE1":963,"PHASE2":965,"PHASE3":967,"PHASE4":973,"NA":975},{"trials":962,"activeCount":89},[],{"trials":964,"activeCount":89},[],{"trials":966,"activeCount":89},[],{"trials":968,"activeCount":89},[969],{"nctId":945,"briefTitle":946,"status":398,"phases":970,"primaryCompletion":948,"completion":949,"start":950,"enrollment":21,"conditions":971,"interventions":972},[79,80],[952],[934,954],{"trials":974,"activeCount":89},[],{"trials":976,"activeCount":89},[],{"intervention":978,"totalTrials":85,"cells":979},"Pioglitazone 30 mg",{"EARLY_PHASE1":980,"PHASE1":982,"PHASE2":984,"PHASE3":986,"PHASE4":999,"NA":1001},{"trials":981,"activeCount":89},[],{"trials":983,"activeCount":89},[],{"trials":985,"activeCount":89},[],{"trials":987,"activeCount":89},[988],{"nctId":989,"briefTitle":990,"status":432,"phases":991,"primaryCompletion":992,"completion":992,"start":993,"enrollment":89,"conditions":994,"interventions":998},"NCT05098327","Pioglitazone and Insulin Resistance in ADT",[80],"2023-03-31","2021-08-01",[995,996,23,997],"Prostate Cancer","Insulin Resistance","Androgen Deficiency",[978],{"trials":1000,"activeCount":89},[],{"trials":1002,"activeCount":89},[],{"intervention":1004,"totalTrials":85,"cells":1005},"Adrenocorticotropic Hormone",{"EARLY_PHASE1":1006,"PHASE1":1008,"PHASE2":1010,"PHASE3":1012,"PHASE4":1023,"NA":1025},{"trials":1007,"activeCount":89},[],{"trials":1009,"activeCount":89},[],{"trials":1011,"activeCount":89},[],{"trials":1013,"activeCount":89},[1014],{"nctId":1015,"briefTitle":1016,"status":411,"phases":1017,"primaryCompletion":1018,"completion":1018,"start":1019,"enrollment":1020,"conditions":1021,"interventions":1022},"NCT02290444","Effects of Acthar on Recovery From Cognitive Relapses in MS",[80],"2018-11-01","2013-08",64,[14],[1004],{"trials":1024,"activeCount":89},[],{"trials":1026,"activeCount":89},[],{"intervention":869,"totalTrials":85,"cells":1028},{"EARLY_PHASE1":1029,"PHASE1":1031,"PHASE2":1033,"PHASE3":1035,"PHASE4":1041,"NA":1043},{"trials":1030,"activeCount":89},[],{"trials":1032,"activeCount":89},[],{"trials":1034,"activeCount":89},[],{"trials":1036,"activeCount":89},[1037],{"nctId":861,"briefTitle":862,"status":411,"phases":1038,"primaryCompletion":864,"completion":602,"start":666,"enrollment":865,"conditions":1039,"interventions":1040},[80],[867],[869,850,870],{"trials":1042,"activeCount":89},[],{"trials":1044,"activeCount":89},[],{"intervention":870,"totalTrials":85,"cells":1046},{"EARLY_PHASE1":1047,"PHASE1":1049,"PHASE2":1051,"PHASE3":1053,"PHASE4":1059,"NA":1061},{"trials":1048,"activeCount":89},[],{"trials":1050,"activeCount":89},[],{"trials":1052,"activeCount":89},[],{"trials":1054,"activeCount":89},[1055],{"nctId":861,"briefTitle":862,"status":411,"phases":1056,"primaryCompletion":864,"completion":602,"start":666,"enrollment":865,"conditions":1057,"interventions":1058},[80],[867],[869,850,870],{"trials":1060,"activeCount":89},[],{"trials":1062,"activeCount":89},[],{"intervention":879,"totalTrials":85,"cells":1064},{"EARLY_PHASE1":1065,"PHASE1":1067,"PHASE2":1069,"PHASE3":1071,"PHASE4":1077,"NA":1079},{"trials":1066,"activeCount":89},[],{"trials":1068,"activeCount":89},[],{"trials":1070,"activeCount":89},[],{"trials":1072,"activeCount":89},[1073],{"nctId":872,"briefTitle":873,"status":411,"phases":1074,"primaryCompletion":875,"completion":875,"start":876,"enrollment":351,"conditions":1075,"interventions":1076},[80],[867],[879,850],{"trials":1078,"activeCount":89},[],{"trials":1080,"activeCount":89},[],{"intervention":1082,"totalTrials":85,"cells":1083},"Varenicline",{"EARLY_PHASE1":1084,"PHASE1":1086,"PHASE2":1088,"PHASE3":1090,"PHASE4":1103,"NA":1105},{"trials":1085,"activeCount":89},[],{"trials":1087,"activeCount":89},[],{"trials":1089,"activeCount":89},[],{"trials":1091,"activeCount":89},[1092],{"nctId":1093,"briefTitle":1094,"status":411,"phases":1095,"primaryCompletion":1096,"completion":1097,"start":1098,"enrollment":1099,"conditions":1100,"interventions":1102},"NCT03262662","EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking",[80],"2021-04-05","2021-07-08","2017-10-01",320,[1101],"Tobacco Smoking",[1082],{"trials":1104,"activeCount":89},[],{"trials":1106,"activeCount":89},[],{"intervention":840,"totalTrials":85,"cells":1108},{"EARLY_PHASE1":1109,"PHASE1":1111,"PHASE2":1113,"PHASE3":1115,"PHASE4":1121,"NA":1123},{"trials":1110,"activeCount":89},[],{"trials":1112,"activeCount":89},[],{"trials":1114,"activeCount":89},[],{"trials":1116,"activeCount":89},[1117],{"nctId":831,"briefTitle":832,"status":411,"phases":1118,"primaryCompletion":834,"completion":834,"start":835,"enrollment":836,"conditions":1119,"interventions":1120},[80],[838],[792,840,841,842,843,844],{"trials":1122,"activeCount":89},[],{"trials":1124,"activeCount":89},[],{"intervention":841,"totalTrials":85,"cells":1126},{"EARLY_PHASE1":1127,"PHASE1":1129,"PHASE2":1131,"PHASE3":1133,"PHASE4":1139,"NA":1141},{"trials":1128,"activeCount":89},[],{"trials":1130,"activeCount":89},[],{"trials":1132,"activeCount":89},[],{"trials":1134,"activeCount":89},[1135],{"nctId":831,"briefTitle":832,"status":411,"phases":1136,"primaryCompletion":834,"completion":834,"start":835,"enrollment":836,"conditions":1137,"interventions":1138},[80],[838],[792,840,841,842,843,844],{"trials":1140,"activeCount":89},[],{"trials":1142,"activeCount":89},[],{"intervention":842,"totalTrials":85,"cells":1144},{"EARLY_PHASE1":1145,"PHASE1":1147,"PHASE2":1149,"PHASE3":1151,"PHASE4":1157,"NA":1159},{"trials":1146,"activeCount":89},[],{"trials":1148,"activeCount":89},[],{"trials":1150,"activeCount":89},[],{"trials":1152,"activeCount":89},[1153],{"nctId":831,"briefTitle":832,"status":411,"phases":1154,"primaryCompletion":834,"completion":834,"start":835,"enrollment":836,"conditions":1155,"interventions":1156},[80],[838],[792,840,841,842,843,844],{"trials":1158,"activeCount":89},[],{"trials":1160,"activeCount":89},[],{"intervention":843,"totalTrials":85,"cells":1162},{"EARLY_PHASE1":1163,"PHASE1":1165,"PHASE2":1167,"PHASE3":1169,"PHASE4":1175,"NA":1177},{"trials":1164,"activeCount":89},[],{"trials":1166,"activeCount":89},[],{"trials":1168,"activeCount":89},[],{"trials":1170,"activeCount":89},[1171],{"nctId":831,"briefTitle":832,"status":411,"phases":1172,"primaryCompletion":834,"completion":834,"start":835,"enrollment":836,"conditions":1173,"interventions":1174},[80],[838],[792,840,841,842,843,844],{"trials":1176,"activeCount":89},[],{"trials":1178,"activeCount":89},[],{"intervention":844,"totalTrials":85,"cells":1180},{"EARLY_PHASE1":1181,"PHASE1":1183,"PHASE2":1185,"PHASE3":1187,"PHASE4":1193,"NA":1195},{"trials":1182,"activeCount":89},[],{"trials":1184,"activeCount":89},[],{"trials":1186,"activeCount":89},[],{"trials":1188,"activeCount":89},[1189],{"nctId":831,"briefTitle":832,"status":411,"phases":1190,"primaryCompletion":834,"completion":834,"start":835,"enrollment":836,"conditions":1191,"interventions":1192},[80],[838],[792,840,841,842,843,844],{"trials":1194,"activeCount":89},[],{"trials":1196,"activeCount":89},[],{"intervention":1198,"totalTrials":442,"cells":1199},"Chlorhexidine gluconate oral rinse",{"EARLY_PHASE1":1200,"PHASE1":1202,"PHASE2":1204,"PHASE3":1228,"PHASE4":1230,"NA":1232},{"trials":1201,"activeCount":89},[],{"trials":1203,"activeCount":89},[],{"trials":1205,"activeCount":89},[1206,1217],{"nctId":1207,"briefTitle":1208,"status":411,"phases":1209,"primaryCompletion":1210,"completion":1210,"start":1211,"enrollment":1212,"conditions":1213,"interventions":1216},"NCT04830969","Impact of Periodontal Therapy on Patients With Diabetes",[79],"2021-01-28","2016-11-08",116,[1214,1215],"Diabetes Mellitus, Type II","Periodontitis",[1198],{"nctId":1218,"briefTitle":1219,"status":411,"phases":1220,"primaryCompletion":1221,"completion":1221,"start":1222,"enrollment":1223,"conditions":1224,"interventions":1226},"NCT00123123","Effect of Improved Oral Hygiene to Prevent Pneumonia in Hospitalized Patients",[79],"2007-11","2004-03",175,[1225],"Pneumonia",[1227],"chlorhexidine gluconate oral rinse",{"trials":1229,"activeCount":89},[],{"trials":1231,"activeCount":89},[],{"trials":1233,"activeCount":89},[],{"intervention":1235,"totalTrials":442,"cells":1236},"Lithium",{"EARLY_PHASE1":1237,"PHASE1":1239,"PHASE2":1251,"PHASE3":1263,"PHASE4":1265,"NA":1267},{"trials":1238,"activeCount":89},[],{"trials":1240,"activeCount":89},[1241],{"nctId":1242,"briefTitle":1243,"status":411,"phases":1244,"primaryCompletion":1245,"completion":1246,"start":1247,"enrollment":425,"conditions":1248,"interventions":1250},"NCT04273932","Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease.",[78],"2023-06-15","2023-08-12","2019-10-17",[1249],"Parkinson Disease",[1235],{"trials":1252,"activeCount":89},[1253],{"nctId":1254,"briefTitle":1255,"status":411,"phases":1256,"primaryCompletion":1257,"completion":1257,"start":1258,"enrollment":1259,"conditions":1260,"interventions":1262},"NCT05618587","Effect of Lithium Therapy on Long COVID Symptoms",[79],"2023-07-21","2022-11-28",52,[1261],"Long COVID",[1235],{"trials":1264,"activeCount":89},[],{"trials":1266,"activeCount":89},[],{"trials":1268,"activeCount":89},[],{"intervention":1270,"totalTrials":442,"cells":1271},"Melatonin",{"EARLY_PHASE1":1272,"PHASE1":1274,"PHASE2":1276,"PHASE3":1296,"PHASE4":1298,"NA":1300},{"trials":1273,"activeCount":89},[],{"trials":1275,"activeCount":89},[],{"trials":1277,"activeCount":89},[1278,1287],{"nctId":1279,"briefTitle":1280,"status":398,"phases":1281,"primaryCompletion":1282,"completion":1282,"start":1283,"enrollment":21,"conditions":1284,"interventions":1286},"NCT04474483","Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19",[79],"2022-07-22","2020-11-06",[1285],"COVID-19",[1270],{"nctId":1288,"briefTitle":1289,"status":432,"phases":1290,"primaryCompletion":1291,"completion":1292,"start":1293,"enrollment":89,"conditions":1294,"interventions":1295},"NCT04784754","Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19",[79],"2022-09-30","2022-12-31","2021-04-01",[1285],[1270],{"trials":1297,"activeCount":89},[],{"trials":1299,"activeCount":89},[],{"trials":1301,"activeCount":89},[],{"intervention":827,"totalTrials":85,"cells":1303},{"EARLY_PHASE1":1304,"PHASE1":1306,"PHASE2":1308,"PHASE3":1314,"PHASE4":1316,"NA":1318},{"trials":1305,"activeCount":89},[],{"trials":1307,"activeCount":89},[],{"trials":1309,"activeCount":89},[1310],{"nctId":818,"briefTitle":819,"status":411,"phases":1311,"primaryCompletion":821,"completion":822,"start":434,"enrollment":823,"conditions":1312,"interventions":1313},[79],[825],[792,827],{"trials":1315,"activeCount":89},[],{"trials":1317,"activeCount":89},[],{"trials":1319,"activeCount":89},[],{"intervention":1321,"totalTrials":85,"cells":1322},"Semaglutide Pen Injector",{"EARLY_PHASE1":1323,"PHASE1":1325,"PHASE2":1327,"PHASE3":1340,"PHASE4":1342,"NA":1344},{"trials":1324,"activeCount":89},[],{"trials":1326,"activeCount":89},[],{"trials":1328,"activeCount":89},[1329],{"nctId":1330,"briefTitle":1331,"status":411,"phases":1332,"primaryCompletion":1333,"completion":1334,"start":1335,"enrollment":1336,"conditions":1337,"interventions":1339},"NCT05302596","Semaglutide Use in Elderly Obese Patients",[79],"2023-10-23","2024-10-30","2022-09-01",16,[20,1338],"Aging",[1321],{"trials":1341,"activeCount":89},[],{"trials":1343,"activeCount":89},[],{"trials":1345,"activeCount":89},[],{"intervention":1347,"totalTrials":85,"cells":1348},"testosterone",{"EARLY_PHASE1":1349,"PHASE1":1351,"PHASE2":1353,"PHASE3":1365,"PHASE4":1367,"NA":1369},{"trials":1350,"activeCount":89},[],{"trials":1352,"activeCount":89},[],{"trials":1354,"activeCount":89},[1355],{"nctId":1356,"briefTitle":1357,"status":398,"phases":1358,"primaryCompletion":1359,"completion":1359,"start":1360,"enrollment":29,"conditions":1361,"interventions":1363},"NCT01155518","Hypogonadism in Young Men With Type 2 Diabetes",[79],"2013-12","2010-06",[1362,28],"Hypogonadotropic Hypogonadism",[1347,1364],"clomiphene",{"trials":1366,"activeCount":89},[],{"trials":1368,"activeCount":89},[],{"trials":1370,"activeCount":89},[],{"intervention":1364,"totalTrials":85,"cells":1372},{"EARLY_PHASE1":1373,"PHASE1":1375,"PHASE2":1377,"PHASE3":1383,"PHASE4":1385,"NA":1387},{"trials":1374,"activeCount":89},[],{"trials":1376,"activeCount":89},[],{"trials":1378,"activeCount":89},[1379],{"nctId":1356,"briefTitle":1357,"status":398,"phases":1380,"primaryCompletion":1359,"completion":1359,"start":1360,"enrollment":29,"conditions":1381,"interventions":1382},[79],[1362,28],[1347,1364],{"trials":1384,"activeCount":89},[],{"trials":1386,"activeCount":89},[],{"trials":1388,"activeCount":89},[],{"intervention":1390,"totalTrials":85,"cells":1391},"Minocyclin",{"EARLY_PHASE1":1392,"PHASE1":1394,"PHASE2":1396,"PHASE3":1407,"PHASE4":1409,"NA":1411},{"trials":1393,"activeCount":89},[],{"trials":1395,"activeCount":89},[],{"trials":1397,"activeCount":89},[1398],{"nctId":1399,"briefTitle":1400,"status":432,"phases":1401,"primaryCompletion":1402,"completion":1402,"start":1403,"enrollment":89,"conditions":1404,"interventions":1406},"NCT05367362","Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke",[79],"2026-03-01","2025-12-01",[1405],"Acute Ischemic Stroke",[1390],{"trials":1408,"activeCount":89},[],{"trials":1410,"activeCount":89},[],{"trials":1412,"activeCount":89},[],{"intervention":1414,"totalTrials":85,"cells":1415},"lisdexamfetamine sulfate",{"EARLY_PHASE1":1416,"PHASE1":1418,"PHASE2":1420,"PHASE3":1429,"PHASE4":1431,"NA":1433},{"trials":1417,"activeCount":89},[],{"trials":1419,"activeCount":89},[],{"trials":1421,"activeCount":89},[1422],{"nctId":1423,"briefTitle":1424,"status":411,"phases":1425,"primaryCompletion":811,"completion":811,"start":435,"enrollment":1426,"conditions":1427,"interventions":1428},"NCT01615887","Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple Sclerosis",[79],63,[14],[1414],{"trials":1430,"activeCount":89},[],{"trials":1432,"activeCount":89},[],{"trials":1434,"activeCount":89},[],{"intervention":1436,"totalTrials":85,"cells":1437},"Etanercept",{"EARLY_PHASE1":1438,"PHASE1":1440,"PHASE2":1442,"PHASE3":1454,"PHASE4":1456,"NA":1458},{"trials":1439,"activeCount":89},[],{"trials":1441,"activeCount":89},[],{"trials":1443,"activeCount":89},[1444],{"nctId":1445,"briefTitle":1446,"status":411,"phases":1447,"primaryCompletion":401,"completion":1448,"start":1449,"enrollment":1450,"conditions":1451,"interventions":1453},"NCT00730392","Etanercept in New Onset Type 1 Diabetes",[78,79],"2008-01","2002-10",18,[1452],"Type 1 Diabetes",[1436],{"trials":1455,"activeCount":89},[],{"trials":1457,"activeCount":89},[],{"trials":1459,"activeCount":89},[],{"intervention":1461,"totalTrials":85,"cells":1462},"Botulinum Toxin type A",{"EARLY_PHASE1":1463,"PHASE1":1475,"PHASE2":1477,"PHASE3":1479,"PHASE4":1481,"NA":1483},{"trials":1464,"activeCount":89},[1465],{"nctId":1466,"briefTitle":1467,"status":411,"phases":1468,"primaryCompletion":1469,"completion":1469,"start":1470,"enrollment":1471,"conditions":1472,"interventions":1474},"NCT03346252","The Effect of Botulinum Toxin A on Headache Attributed to TMD",[77],"2021-03-15","2017-05-08",20,[1473],"Secondary Headache Disorder",[1461],{"trials":1476,"activeCount":89},[],{"trials":1478,"activeCount":89},[],{"trials":1480,"activeCount":89},[],{"trials":1482,"activeCount":89},[],{"trials":1484,"activeCount":89},[],{"intervention":1486,"totalTrials":85,"cells":1487},"Ipratropium Bromide",{"EARLY_PHASE1":1488,"PHASE1":1502,"PHASE2":1504,"PHASE3":1506,"PHASE4":1508,"NA":1510},{"trials":1489,"activeCount":89},[1490],{"nctId":1491,"briefTitle":1492,"status":411,"phases":1493,"primaryCompletion":1494,"completion":1494,"start":1495,"enrollment":1496,"conditions":1497,"interventions":1501},"NCT04617015","Defining and Treating Depression-related Asthma",[77],"2019-03-11","2016-09-09",39,[1498,1499,1500],"Asthma","Depression","Childhood Asthma",[1486],{"trials":1503,"activeCount":89},[],{"trials":1505,"activeCount":89},[],{"trials":1507,"activeCount":89},[],{"trials":1509,"activeCount":89},[],{"trials":1511,"activeCount":89},[],{"intervention":1513,"totalTrials":442,"cells":1514},"Mutation analysis",{"EARLY_PHASE1":1515,"PHASE1":1517,"PHASE2":1519,"PHASE3":1521,"PHASE4":1523,"NA":1525},{"trials":1516,"activeCount":89},[],{"trials":1518,"activeCount":89},[],{"trials":1520,"activeCount":89},[],{"trials":1522,"activeCount":89},[],{"trials":1524,"activeCount":89},[],{"trials":1526,"activeCount":89},[1527,1539],{"nctId":1528,"briefTitle":1529,"status":411,"phases":1530,"primaryCompletion":1531,"completion":1531,"start":1532,"enrollment":1533,"conditions":1534,"interventions":1538},"NCT04580979","Natural History Study of FDXR Mutation-related Mitochondriopathy",[],"2023-08-17","2020-11-03",33,[1535,1536,1537],"Neurodegenerative Disease, Hereditary","Mitochondrial Diseases","Optic Atrophy",[1513],{"nctId":1540,"briefTitle":1541,"status":411,"phases":1542,"primaryCompletion":1531,"completion":1531,"start":1532,"enrollment":18,"conditions":1543,"interventions":1544},"NCT04594590","Natural History Study of SLC25A46 Mutation-related Mitochondriopathy",[],[1535,1536,1537],[1513],{"intervention":1546,"totalTrials":85,"cells":1547},"Rasagiline",{"EARLY_PHASE1":1548,"PHASE1":1550,"PHASE2":1552,"PHASE3":1554,"PHASE4":1556,"NA":1558},{"trials":1549,"activeCount":89},[],{"trials":1551,"activeCount":89},[],{"trials":1553,"activeCount":89},[],{"trials":1555,"activeCount":89},[],{"trials":1557,"activeCount":89},[],{"trials":1559,"activeCount":89},[1560],{"nctId":1561,"briefTitle":1562,"status":411,"phases":1563,"primaryCompletion":1564,"completion":1564,"start":1565,"enrollment":1566,"conditions":1567,"interventions":1569},"NCT02278588","Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease.",[],"2017-12","2014-11",45,[1568],"Parkinson's Disease",[1546],{"intervention":1571,"totalTrials":85,"cells":1572},"Bictegravir\u002FEmtricitabine\u002FTenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]",{"EARLY_PHASE1":1573,"PHASE1":1575,"PHASE2":1577,"PHASE3":1579,"PHASE4":1581,"NA":1583},{"trials":1574,"activeCount":89},[],{"trials":1576,"activeCount":89},[],{"trials":1578,"activeCount":89},[],{"trials":1580,"activeCount":89},[],{"trials":1582,"activeCount":89},[],{"trials":1584,"activeCount":89},[1585],{"nctId":1586,"briefTitle":1587,"status":1588,"phases":1589,"primaryCompletion":483,"completion":483,"start":1590,"enrollment":1591,"conditions":1592,"interventions":1594},"NCT05064020","Bictegravir in the Elderly Living With HIV (BICEP)","UNKNOWN",[],"2020-08-01",162,[1593],"HIV-1-infection",[1571],{"intervention":1596,"totalTrials":85,"cells":1597},"0% nitrous oxide, 30% nitrous oxide and 60% nitrous oxide",{"EARLY_PHASE1":1598,"PHASE1":1600,"PHASE2":1602,"PHASE3":1604,"PHASE4":1606,"NA":1608},{"trials":1599,"activeCount":89},[],{"trials":1601,"activeCount":89},[],{"trials":1603,"activeCount":89},[],{"trials":1605,"activeCount":89},[],{"trials":1607,"activeCount":89},[],{"trials":1609,"activeCount":89},[1610],{"nctId":1611,"briefTitle":1612,"status":411,"phases":1613,"primaryCompletion":1614,"completion":1614,"start":1615,"enrollment":1616,"conditions":1617,"interventions":1619},"NCT02050152","Nitrous Oxide Induction Induces Amnesia in Pediatric Patients",[82],"2013-10","2013-05",90,[1618],"Amnesia",[1596],{"intervention":1621,"totalTrials":85,"cells":1622},"Low Caffeine Administration first",{"EARLY_PHASE1":1623,"PHASE1":1625,"PHASE2":1627,"PHASE3":1629,"PHASE4":1631,"NA":1633},{"trials":1624,"activeCount":89},[],{"trials":1626,"activeCount":89},[],{"trials":1628,"activeCount":89},[],{"trials":1630,"activeCount":89},[],{"trials":1632,"activeCount":89},[],{"trials":1634,"activeCount":89},[1635],{"nctId":1636,"briefTitle":1637,"status":411,"phases":1638,"primaryCompletion":1639,"completion":1639,"start":811,"enrollment":1640,"conditions":1641,"interventions":1642},"NCT02119416","Gender Difference in Response to Caffeine in Children and Adolescents",[82],"2012-10",101,[33],[1621,1643],"High Caffeine Administration first",{"intervention":1643,"totalTrials":85,"cells":1645},{"EARLY_PHASE1":1646,"PHASE1":1648,"PHASE2":1650,"PHASE3":1652,"PHASE4":1654,"NA":1656},{"trials":1647,"activeCount":89},[],{"trials":1649,"activeCount":89},[],{"trials":1651,"activeCount":89},[],{"trials":1653,"activeCount":89},[],{"trials":1655,"activeCount":89},[],{"trials":1657,"activeCount":89},[1658],{"nctId":1636,"briefTitle":1637,"status":411,"phases":1659,"primaryCompletion":1639,"completion":1639,"start":811,"enrollment":1640,"conditions":1660,"interventions":1661},[82],[33],[1621,1643],{"intervention":1663,"totalTrials":85,"cells":1664},"oxygen concentration",{"EARLY_PHASE1":1665,"PHASE1":1667,"PHASE2":1669,"PHASE3":1671,"PHASE4":1673,"NA":1675},{"trials":1666,"activeCount":89},[],{"trials":1668,"activeCount":89},[],{"trials":1670,"activeCount":89},[],{"trials":1672,"activeCount":89},[],{"trials":1674,"activeCount":89},[],{"trials":1676,"activeCount":89},[1677],{"nctId":1678,"briefTitle":1679,"status":411,"phases":1680,"primaryCompletion":1681,"completion":1681,"start":1682,"enrollment":823,"conditions":1683,"interventions":1686},"NCT02725164","Anesthetic Gas Leakage in Children During Tonsillectomy: a Comparison of Cuffed and Uncuffed Tracheal Tubes",[82],"2016-06-01","2016-04-12",[1684,1685],"Exposure to Environmental Pollution","Adverse Effect of Unspecified General Anesthetic",[1663,1687,1688,1689],"nitrous oxide concentration","carbon dioxide concentration","sevoflurane concentration",{"intervention":1687,"totalTrials":85,"cells":1691},{"EARLY_PHASE1":1692,"PHASE1":1694,"PHASE2":1696,"PHASE3":1698,"PHASE4":1700,"NA":1702},{"trials":1693,"activeCount":89},[],{"trials":1695,"activeCount":89},[],{"trials":1697,"activeCount":89},[],{"trials":1699,"activeCount":89},[],{"trials":1701,"activeCount":89},[],{"trials":1703,"activeCount":89},[1704],{"nctId":1678,"briefTitle":1679,"status":411,"phases":1705,"primaryCompletion":1681,"completion":1681,"start":1682,"enrollment":823,"conditions":1706,"interventions":1707},[82],[1684,1685],[1663,1687,1688,1689],{"intervention":1688,"totalTrials":85,"cells":1709},{"EARLY_PHASE1":1710,"PHASE1":1712,"PHASE2":1714,"PHASE3":1716,"PHASE4":1718,"NA":1720},{"trials":1711,"activeCount":89},[],{"trials":1713,"activeCount":89},[],{"trials":1715,"activeCount":89},[],{"trials":1717,"activeCount":89},[],{"trials":1719,"activeCount":89},[],{"trials":1721,"activeCount":89},[1722],{"nctId":1678,"briefTitle":1679,"status":411,"phases":1723,"primaryCompletion":1681,"completion":1681,"start":1682,"enrollment":823,"conditions":1724,"interventions":1725},[82],[1684,1685],[1663,1687,1688,1689],{"intervention":1689,"totalTrials":85,"cells":1727},{"EARLY_PHASE1":1728,"PHASE1":1730,"PHASE2":1732,"PHASE3":1734,"PHASE4":1736,"NA":1738},{"trials":1729,"activeCount":89},[],{"trials":1731,"activeCount":89},[],{"trials":1733,"activeCount":89},[],{"trials":1735,"activeCount":89},[],{"trials":1737,"activeCount":89},[],{"trials":1739,"activeCount":89},[1740],{"nctId":1678,"briefTitle":1679,"status":411,"phases":1741,"primaryCompletion":1681,"completion":1681,"start":1682,"enrollment":823,"conditions":1742,"interventions":1743},[82],[1684,1685],[1663,1687,1688,1689],{"intervention":1745,"totalTrials":85,"cells":1746},"Avonex® monotherapy",{"EARLY_PHASE1":1747,"PHASE1":1749,"PHASE2":1751,"PHASE3":1753,"PHASE4":1755,"NA":1757},{"trials":1748,"activeCount":89},[],{"trials":1750,"activeCount":89},[],{"trials":1752,"activeCount":89},[],{"trials":1754,"activeCount":89},[],{"trials":1756,"activeCount":89},[],{"trials":1758,"activeCount":89},[1759],{"nctId":1760,"briefTitle":1761,"status":411,"phases":1762,"completion":1763,"start":1764,"enrollment":1765,"conditions":1766,"interventions":1767},"NCT00463710","Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MS",[],"2006-09","2005-06",150,[14],[1745],{"intervention":1769,"totalTrials":85,"cells":1770},"metronidazole",{"EARLY_PHASE1":1771,"PHASE1":1773,"PHASE2":1775,"PHASE3":1777,"PHASE4":1779,"NA":1781},{"trials":1772,"activeCount":89},[],{"trials":1774,"activeCount":89},[],{"trials":1776,"activeCount":89},[],{"trials":1778,"activeCount":89},[],{"trials":1780,"activeCount":89},[],{"trials":1782,"activeCount":89},[1783],{"nctId":1784,"briefTitle":1785,"status":432,"phases":1786,"primaryCompletion":602,"completion":602,"start":900,"enrollment":89,"conditions":1787,"interventions":1789},"NCT01472978","Prospective Study of Clostridium Difficile in Children Undergoing Colonoscopy",[82],[1788],"C. Difficile Infection",[1769],{"intervention":1791,"totalTrials":85,"cells":1792},"Olanzapine",{"EARLY_PHASE1":1793,"PHASE1":1795,"PHASE2":1797,"PHASE3":1799,"PHASE4":1801,"NA":1803},{"trials":1794,"activeCount":89},[],{"trials":1796,"activeCount":89},[],{"trials":1798,"activeCount":89},[],{"trials":1800,"activeCount":89},[],{"trials":1802,"activeCount":89},[],{"trials":1804,"activeCount":89},[1805],{"nctId":1806,"briefTitle":1807,"status":411,"phases":1808,"primaryCompletion":1809,"completion":1809,"start":401,"enrollment":1810,"conditions":1811,"interventions":1812},"NCT01496183","Metabolic Effects of Olanzapine in Healthy Males",[82],"2013-04",24,[33],[1791],{"intervention":1814,"totalTrials":85,"cells":1815},"beclamethasone dipropionate",{"EARLY_PHASE1":1816,"PHASE1":1818,"PHASE2":1820,"PHASE3":1822,"PHASE4":1824,"NA":1826},{"trials":1817,"activeCount":89},[],{"trials":1819,"activeCount":89},[],{"trials":1821,"activeCount":89},[],{"trials":1823,"activeCount":89},[],{"trials":1825,"activeCount":89},[],{"trials":1827,"activeCount":89},[1828],{"nctId":1829,"briefTitle":1830,"status":398,"phases":1831,"primaryCompletion":1832,"completion":1832,"start":1833,"enrollment":604,"conditions":1834,"interventions":1836},"NCT02499887","Repeat Emergency Department Visits Among Patients With Asthma and COPD",[82],"2016-09","2016-01",[1498,1835],"COPD",[1814,1837,1838],"albuterol","Prednisone",{"intervention":1837,"totalTrials":85,"cells":1840},{"EARLY_PHASE1":1841,"PHASE1":1843,"PHASE2":1845,"PHASE3":1847,"PHASE4":1849,"NA":1851},{"trials":1842,"activeCount":89},[],{"trials":1844,"activeCount":89},[],{"trials":1846,"activeCount":89},[],{"trials":1848,"activeCount":89},[],{"trials":1850,"activeCount":89},[],{"trials":1852,"activeCount":89},[1853],{"nctId":1829,"briefTitle":1830,"status":398,"phases":1854,"primaryCompletion":1832,"completion":1832,"start":1833,"enrollment":604,"conditions":1855,"interventions":1856},[82],[1498,1835],[1814,1837,1838],{"intervention":1838,"totalTrials":85,"cells":1858},{"EARLY_PHASE1":1859,"PHASE1":1861,"PHASE2":1863,"PHASE3":1865,"PHASE4":1867,"NA":1869},{"trials":1860,"activeCount":89},[],{"trials":1862,"activeCount":89},[],{"trials":1864,"activeCount":89},[],{"trials":1866,"activeCount":89},[],{"trials":1868,"activeCount":89},[],{"trials":1870,"activeCount":89},[1871],{"nctId":1829,"briefTitle":1830,"status":398,"phases":1872,"primaryCompletion":1832,"completion":1832,"start":1833,"enrollment":604,"conditions":1873,"interventions":1874},[82],[1498,1835],[1814,1837,1838],{"intervention":1876,"totalTrials":85,"cells":1877},"Magnesium Sulfate",{"EARLY_PHASE1":1878,"PHASE1":1880,"PHASE2":1882,"PHASE3":1884,"PHASE4":1886,"NA":1888},{"trials":1879,"activeCount":89},[],{"trials":1881,"activeCount":89},[],{"trials":1883,"activeCount":89},[],{"trials":1885,"activeCount":89},[],{"trials":1887,"activeCount":89},[],{"trials":1889,"activeCount":89},[1890],{"nctId":1891,"briefTitle":1892,"status":411,"phases":1893,"primaryCompletion":1894,"completion":1894,"start":1895,"enrollment":1896,"conditions":1897,"interventions":1899},"NCT01597557","Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial",[82],"2014-02","2012-04",261,[1898],"Atrial Fibrillation",[1876],{"intervention":1901,"totalTrials":85,"cells":1902},"The washin of sevoflurane in the GE Ohmeda workstation",{"EARLY_PHASE1":1903,"PHASE1":1905,"PHASE2":1907,"PHASE3":1909,"PHASE4":1911,"NA":1913},{"trials":1904,"activeCount":89},[],{"trials":1906,"activeCount":89},[],{"trials":1908,"activeCount":89},[],{"trials":1910,"activeCount":89},[],{"trials":1912,"activeCount":89},[],{"trials":1914,"activeCount":89},[1915],{"nctId":1916,"briefTitle":1917,"status":411,"phases":1918,"primaryCompletion":1919,"completion":1919,"start":1920,"enrollment":1810,"conditions":1921,"interventions":1924},"NCT06510803","Sevoflurane Concentrations in Children",[],"2024-10-24","2024-09-18",[1922,608,1923],"Anesthetic","Age",[1901]]